R&D Systems Inc. Tocris Bioscience Boston Biochem

Glycogen Synthase Kinase 3 - Peptides

Inhibitors
Cat.No.
Product Name / Activity
1835 FRATide
GSK-3 inhibitor
2235 L803
Substrate-competitive inhibitor of GSK-3
2256 L803-mts
Selective inhibitor of GSK-3
Substrates
Cat.No.
Product Name / Activity
1802 2B-(SP)
Selective GSK-3 phosphopeptide substrate
1352 Phospho-Glycogen Synthase Peptide-2 (substrate)
GSK-3 substrate (synthetic)
Other
Cat.No.
Product Name / Activity
2236 TCS 183
Fragment 1-13 of GSK-3β sequence
2320 TCS 184
Scrambled control peptide for use with TCS 183 (Cat. No. 2236)
View all Glycogen Synthase Kinase 3 products

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Guide

Request your free copy

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

Kinases Product Listing

Kinases Product Listing

Highlights over 350 products for kinase research. Request a copy or view PDF today.

divider line

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Some of the most potent
kinase inhibitors all on one plate

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

divider line

Therapeutic Strategies in Schizophrenia

Written by J. Lieberman

Schizophrenia Poster

'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.

divider line

The Neurobiology of Alzheimer's Disease

Written by Alan Palmer

Alzheimer's Poster

'The Neurobiology of Alzheimer's Disease' summarizes structural and functional changes observed in the progression of AD.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions